Condensations of aryl trifluoromethyl ketones with arenes in acidic media
摘要:
The chemistry of trifluoromethyl ketones has been studied. The work examines the condensation reactions of trifluoromethyl ketones with arenes in the superacid, including both synthetic and mechanistic aspects. (C) 2010 Elsevier Ltd. All rights reserved.
1,1,1-Triaryl-2,2,2-trifluoroethanes and process for their synthesis
申请人:——
公开号:US04307024A1
公开(公告)日:1981-12-22
New 1,1,1-triaryl-2,2,2-trifluoroethanes in which the aryl radicals carry one or more substitutents have been prepared by condensation of trifluoroacetophenones with substituted phenyl compounds in the presence of catalytic quantities of trifluoromethylsulfonic acid. The reaction can be carried out under reflux in toluene or, for strikingly better results in certain cases, reactants are simply stirred at room temperature for about 24 to 48 hours.
OLIGONUCLEOTIDE ANALOGUES HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS
申请人:Hanson Gunnar J.
公开号:US20120065169A1
公开(公告)日:2012-03-15
Oligonucleotide analogues comprising modified intersubunit linkages and/or modified 3′ and/or 5′-end groups are provided. The disclosed compounds are useful for the treatment of diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.
Oligonucleotide analogues conjugated to carrier peptides are provided. The disclosed compounds are useful for the treatment of various diseases, for example diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.
dsRNA molecules comprising oligonucleotide analogs having modified intersubunit linkages and/or terminal groups
申请人:Iversen Patrick L.
公开号:US10017763B2
公开(公告)日:2018-07-10
Morpholino oligomers containing modified intersubunit linkages and/or terminal groups are provided for use within dsRNA molecules. The oligomers are oligonucleotide analogs containing predetermined sequences of base-pairing moieties. Also provided are such oligomers conjugated to peptide transporter moieties, where the transporters are preferably composed of arginine subunits, or arginine dimers, alternating with neutral amino acid subunits.
Provided are LMNA-targeted antisense oligonucleotides for reducing expression of one or more aberrantly spliced LMNA mRNA isoforms that encode progerin.